US Congress House Bill 5366 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on May 26 2016 - 25% progression, died in committee
Action: 2016-05-26 - Referred to the House Committee on Ways and Means.
Pending: House Ways And Means Committee
Text: Latest bill text (Introduced) [PDF]

Alzheimer's Breakthrough Sunshine Act This bill amends the Internal Revenue Code to exclude from gross income for seven years amounts received from the sale of certain drugs for treating Alzheimer's disease and related dementias. The exclusion applies to the sale of a drug approved or licensed as a disease-modifying treatment for Alzheimer's disease and that has been designated as a breakthrough therapy under the Federal Food, Drug, and Cosmetic Act. The drug must be sold through an arm's length transaction by a holder of the approved application for the drug.

Alzheimer's Breakthrough Sunshine Act

Rep. Patrick Murphy [D-FL]

Rep. Michael Fitzpatrick [R-PA]

Date	Chamber	Action
2016-05-26	House	Referred to the House Committee on Ways and Means.
2016-05-26	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/house-bill/5366/all-info
Text	https://www.congress.gov/114/bills/hr5366/BILLS-114hr5366ih.pdf